Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019 : Do Blood Concentrations Matter?
| Errataetall: |
CommentIn: Clin Infect Dis. 2020 Dec 3;71(9):2469-2479. - PMID 32392337 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 71(2020), 11 vom: 31. Dez., Seite 2965-2967 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ippolito, Matthew M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 06.01.2021 Date Revised 07.12.2022 published: Print CommentIn: Clin Infect Dis. 2020 Dec 3;71(9):2469-2479. - PMID 32392337 Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciaa691 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310550246 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310550246 | ||
| 003 | DE-627 | ||
| 005 | 20231225140336.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciaa691 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1035.xml |
| 035 | |a (DE-627)NLM310550246 | ||
| 035 | |a (NLM)32474576 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ippolito, Matthew M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019 |b Do Blood Concentrations Matter? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.01.2021 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Clin Infect Dis. 2020 Dec 3;71(9):2469-2479. - PMID 32392337 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a editorial | |
| 650 | 4 | |a hydroxychloroquine | |
| 650 | 4 | |a pharmacokinetics | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 700 | 1 | |a Flexner, Charles |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 71(2020), 11 vom: 31. Dez., Seite 2965-2967 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:71 |g year:2020 |g number:11 |g day:31 |g month:12 |g pages:2965-2967 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa691 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 71 |j 2020 |e 11 |b 31 |c 12 |h 2965-2967 | ||